CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 115 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $5,746,000 | +18.6% | 1,641,804 | 0.0% | 15.17% | -13.7% |
Q2 2022 | $4,843,000 | -5.2% | 1,641,804 | 0.0% | 17.57% | +12.9% |
Q1 2022 | $5,106,000 | -8.0% | 1,641,804 | 0.0% | 15.56% | +10.8% |
Q4 2021 | $5,549,000 | -7.4% | 1,641,804 | 0.0% | 14.05% | +69.0% |
Q3 2021 | $5,993,000 | -16.3% | 1,641,804 | 0.0% | 8.31% | +9.5% |
Q2 2021 | $7,158,000 | -4.0% | 1,641,804 | 0.0% | 7.59% | +15.9% |
Q1 2021 | $7,454,000 | -20.9% | 1,641,804 | 0.0% | 6.54% | -40.3% |
Q4 2020 | $9,424,000 | -20.7% | 1,641,804 | 0.0% | 10.95% | +23.8% |
Q3 2020 | $11,887,000 | +112.9% | 1,641,804 | +2.6% | 8.85% | +78.3% |
Q2 2020 | $5,584,000 | +89.4% | 1,599,958 | +6.3% | 4.96% | +200.4% |
Q4 2019 | $2,949,000 | -61.8% | 1,504,710 | -0.2% | 1.65% | -43.9% |
Q3 2019 | $7,721,000 | -32.1% | 1,508,091 | -5.0% | 2.95% | -20.9% |
Q2 2019 | $11,364,000 | -46.1% | 1,587,101 | 0.0% | 3.73% | -32.1% |
Q1 2019 | $21,077,000 | +68.8% | 1,587,101 | 0.0% | 5.49% | +33.7% |
Q4 2018 | $12,490,000 | -27.8% | 1,587,101 | +1.6% | 4.10% | +7.4% |
Q3 2018 | $17,307,000 | -17.4% | 1,562,040 | 0.0% | 3.82% | -15.4% |
Q2 2018 | $20,963,000 | +3.3% | 1,562,040 | 0.0% | 4.51% | +2.1% |
Q1 2018 | $20,291,000 | +267.6% | 1,562,040 | +160.3% | 4.42% | +185.5% |
Q4 2017 | $5,520,000 | +14.1% | 600,000 | 0.0% | 1.55% | +16.3% |
Q3 2017 | $4,836,000 | – | 600,000 | – | 1.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 2,254,502 | $20,741,000 | 14.54% |
Versant Venture Management, LLC | 1,048,601 | $9,647,127,000 | 10.15% |
Abingworth LLP | 1,147,077 | $10,553,000 | 7.65% |
Omega Fund Management, LLC | 551,477 | $5,074,000 | 3.67% |
Opaleye Management Inc. | 665,000 | $6,118,000 | 1.96% |
DAFNA Capital Management LLC | 361,164 | $3,323,000 | 1.79% |
Boxer Capital, LLC | 1,012,986 | $9,319,000 | 1.70% |
Foresite Capital Management III, LLC | 600,000 | $5,520,000 | 1.55% |
NEXTHERA CAPITAL LP | 536,568 | $4,936,000 | 0.91% |
Perceptive Advisors | 2,685,882 | $24,710,000 | 0.82% |